Current Report Filing (8-k)
October 28 2019 - 7:07AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 28, 2019
WALGREENS BOOTS ALLIANCE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-36759
|
|
47-1758322
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification Number)
|
|
|
108 Wilmot Road, Deerfield, Illinois
|
|
60015
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(847) 315-2500
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock, $0.01 par value
|
|
WBA
|
|
The Nasdaq Stock Market LLC
|
2.875% Walgreens Boots Alliance, Inc. notes due 2020
|
|
WBA20
|
|
The Nasdaq Stock Market LLC
|
3.600% Walgreens Boots Alliance, Inc. notes due 2025
|
|
WBA25
|
|
The Nasdaq Stock Market LLC
|
2.125% Walgreens Boots Alliance, Inc. notes due 2026
|
|
WBA26
|
|
The Nasdaq Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
|
Results of Operations and Financial Condition.
|
On October 28, 2018, Walgreens Boots Alliance, Inc. (the Company) issued a press release announcing financial results for the
fiscal quarter and fiscal year ended August 31, 2019 and related matters. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated in this Item 2.02 by reference.
The information in this Item 2.02, including the exhibit attached hereto, and the information under Item 7.01 below, shall not be deemed
filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such disclosure in this Form 8-K in such a filing.
Item 7.01.
|
Regulation FD Disclosure.
|
On October 28, 2019, the Company is conducting a conference call and webcast beginning at 8:30 a.m. Eastern time regarding its results for
the fiscal quarter and fiscal year ended August 31, 2019 and related matters.
Slides prepared for the purposes of the conference
call are available on the Companys investor relations website at http://investor.walgreensbootsalliance.com. A link to the conference call will be available on the Companys investor relations website at:
http://investor.walgreensbootsalliance.com.
Item 9.01.
|
Financial Statements and Exhibits.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
WALGREENS BOOTS ALLIANCE, INC.
|
|
|
|
Date: October 28, 2019
|
|
By:
|
|
/s/ James Kehoe
|
|
|
Title:
|
|
Executive Vice President and
Global Chief
Financial Officer
|
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Apr 2023 to Apr 2024